NOD2/RIG-I Activating Inarigivir Adjuvant Enhances the Efficacy of BCG Vaccine Against Tuberculosis in Mice

Tuberculosis (TB) caused by Mycobacterium tuberculosis (MTB) kills about 1.5 million people each year and the widely used Bacille Calmette-Guérin (BCG) vaccine provides a partial protection against TB in children and adults. Because BCG vaccine evades lysosomal fusion in antigen presenting cells (AP...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Khan, Arshad, Singh, Vipul K., Mishra, Abhishek, Soudani, Emily, Bakhru, Pearl, Singh, Christopher R., Zhang, Dekai, Canaday, David H., Sheri, Anjaneyulu, Padmanabhan, Seetharamaiyer, Challa, Sreerupa, Iyer, Radhakrishnan P., Jagannath, Chinnaswamy
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7751440/
https://ncbi.nlm.nih.gov/pubmed/33365029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.592333
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados